BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Lymphoma Research Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://lymphoma.org
X-WR-CALDESC:Events for Lymphoma Research Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240807T140000
DTEND;TZID=America/New_York:20240807T150000
DTSTAMP:20240711T152644Z
CREATED:20240711T152639Z
LAST-MODIFIED:20240711T152644Z
UID:10000133-1723039200-1723042800@lymphoma.org
SUMMARY:Información sobre CAR T-Cell Therapy
DESCRIPTION:Descripción general del programa\n\n\n\n\n¿Qué es la terapia de células T con receptor de antígeno quimérico (CAR)?\n\n\n\n¿Cuándo se debería considerar la terapia de células T con CAR como opción de tratamiento para el linfoma?\n\n\n\nLa consulta con un especialista de células T con CAR\n\n\n\nEstudios clínicos para la terapia de células T con CAR\n\n\n\nCómo tratar los posibles efectos secundarios del tratamiento\n\n\n\nLos beneficios de la terapia de células T con CAR\n\n\n\nCuidados durante el seguimiento: Qué se espera\n\n\n\nSesión de preguntas y respuestas
URL:https://lymphoma.org/event/informacion-sobre-car-t-cell-therapy-2/
CATEGORIES:Patient & Care Partner Education
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240808T150000
DTEND;TZID=America/New_York:20240808T170000
DTSTAMP:20240606T194753Z
CREATED:20240606T194748Z
LAST-MODIFIED:20240606T194753Z
UID:10000126-1723129200-1723136400@lymphoma.org
SUMMARY:Ask the Doctor: Information for Relapsed/Refractory Patients
DESCRIPTION:Ask the Doctor is a national series of two-hour\, topic-specific\, community-based programs that combine a presentation by a medical doctor with an extensive question and answer session. Virtual Ask the Doctor programs provide access to local lymphoma experts\, and you can tune in over the phone or online. Note: Ask the Doctor programs are not recorded or archived. We encourage you to tune in live. \n\n\n\nThis program will cover topics for lymphoma patients who have relapsed or whose disease is no longer responding to treatment. It is geared towards patients and caregivers.
URL:https://lymphoma.org/event/ask-the-doctor-information-for-relapsed-refractory-patients-3/
LOCATION:Virtual
CATEGORIES:Patient & Care Partner Education
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240815T130000
DTEND;TZID=America/New_York:20240815T140000
DTSTAMP:20240711T200619Z
CREATED:20240711T153813Z
LAST-MODIFIED:20240711T200619Z
UID:10000134-1723726800-1723730400@lymphoma.org
SUMMARY:Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma Webinar
DESCRIPTION:Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)\n\n\n\nConsidering Second- and Third-Line Treatment Options\n\n\n\nUpdate on Clinical Trials\n\n\n\nQuestion and Answer Session
URL:https://lymphoma.org/event/update-on-relapsed-refractory-diffuse-large-b-cell-lymphoma/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240828T080000
DTEND;TZID=America/New_York:20240828T170000
DTSTAMP:20240828T214552Z
CREATED:20240828T214549Z
LAST-MODIFIED:20240828T214552Z
UID:10000149-1724832000-1724864400@lymphoma.org
SUMMARY:Washington\, DC Lymphoma Rounds
DESCRIPTION:This Washington DC Lymphoma Rounds provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area. Please note that this program is only open to practicing lymphoma physicians and industry supporters. 
URL:https://lymphoma.org/event/washington-dc-lymphoma-rounds-3/
LOCATION:Westin Arlington\, 801 N Glebe Road\, Arlington\, Virginia\, 22203
CATEGORIES:Professional Education
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240828T140000
DTEND;TZID=America/New_York:20240828T150000
DTSTAMP:20240717T135719Z
CREATED:20240717T135714Z
LAST-MODIFIED:20240717T135719Z
UID:10000137-1724853600-1724857200@lymphoma.org
SUMMARY:Update on Mantle Cell Lymphoma
DESCRIPTION:Overview of Mantle Cell Lymphoma (MCL)\n\n\n\nTreatment Options for Newly Diagnosed Patients\n\n\n\nClinical Trials for MCL\n\n\n\nEmerging Treatment Approaches\n\n\n\nQuality of Life Concerns\n\n\n\nQuestions and Answers
URL:https://lymphoma.org/event/update-on-mantle-cell-lymphoma/
END:VEVENT
END:VCALENDAR